CVS Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

76.510

Open

76.000

VWAP

75.85

Vol

5.53M

Mkt Cap

96.33B

Low

75.320

Amount

419.56M

EV/EBITDA(TTM)

8.84

Total Shares

1.27B

EV

150.47B

EV/OCF(TTM)

14.14

P/S(TTM)

0.24

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

Show More

Events Timeline

(ET)

2026-03-11

12:00:00

CVS Health's Aetna Agrees to Pay $117.7M to Settle False Claims Allegations

2026-03-05 (ET)

2026-03-05

09:10:00

CVS Health Partners with Google Cloud for Health100 Initiative

2026-02-19 (ET)

2026-02-19

09:30:00

CVS Becomes Official Health Partner of U.S. Soccer Federation

2026-02-10 (ET)

2026-02-10

16:30:00

Major Averages Mixed as Investors Await Jobs Report

2026-02-10

12:20:00

Dow Jones Hits Record High, Major Averages Slightly Up

2026-02-10

09:10:00

Dow Jones Closes at Record Levels, Markets Trade Cautiously

2026-02-10

09:10:00

Expects Margin Improvement in Medicare Business in 2026

News

Barron's

06:00 AMBarron's

Income Fund Excels Thanks to Stocks Like Starbucks, Amgen, and CVS

Barron's

DOJ Reaches Settlement with Aetna Over Medicare Advantage Claims

Barron's

"United Health and 8 Additional Dividend Stocks to Weather an Oil Crisis"

Barron's

9 Dividend Stocks to Weather an Oil Crisis

seekingalpha

03-11seekingalpha

CVS Health's Aetna to Pay $117.7M to Settle Medicare Fraud Allegations

Fool

Investment Strategies Amid Recession Predictions

17 Analyst Rating

Wall Street analysts forecast CVS stock price to rise

16 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

91.00

Averages

96.71

High

105.00

Current: 0.000

Low

91.00

Averages

96.71

High

105.00

Argus

Buy

downgrade

$91 -> $90

AI Analysis

2026-01-28

Reason

Argus

Price Target

$91 -> $90

AI Analysis

2026-01-28

downgrade

Buy

Reason

Argus lowered the firm's price target on CVS Health to $90 from $91 but keeps a Buy rating on the shares. The stock declined by close to 15% after the Centers for Medicare and Medicaid Services proposed a flat 2027 Medicare Advantage reimbursement rate over 2026, but the firm sees this rate as likely to be revised upward before final implementation in April 2026, the analyst tells investors in a research note, adding that should the final rate increase come in lower than the prior year's 5.1% increase, CVS's diversification should be able to mitigate the impact compared to pure play health insurers.

BofA

Buy

maintain

$100 -> $95

2026-01-27

Reason

BofA

Price Target

$100 -> $95

2026-01-27

maintain

Buy

Reason

BofA lowered the firm's price target on CVS Health to $95 from $100 and keeps a Buy rating on the shares after the Centers for Medicare & Medicaid Services announced the proposed policies in the calendar year 2027 Advance Notice are projected to result in a net all-in rate of 2.54%, below the market's general expectation for an increase of 4%-6%. The announcement is a headwind to the Medicare Advantage margin expansion story, says the analyst, who estimates the gross unmitigated headwind to CVS would be more than $1B of Medicare Advantage revenue and margin if the final rates match these advanced rates and CVS makes no offsetting changes to benefits. However, the firm also notes that in the past 14 years, the final rate has come in better than the proposal 64% of the time.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CVS

Unlock Now

Valuation Metrics

The current forward P/E ratio for CVS Health Corp (CVS.N) is 11.66, compared to its 5-year average forward P/E of 10.24. For a more detailed relative valuation and DCF analysis to assess CVS Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

10.24

Current PE

11.66

Overvalued PE

11.64

Undervalued PE

8.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

9.08

Current EV/EBITDA

10.15

Overvalued EV/EBITDA

9.98

Undervalued EV/EBITDA

8.19

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

0.30

Current PS

0.25

Overvalued PS

0.39

Undervalued PS

0.21

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

which has the highest return?

Intellectia · 14 candidates

Market Cap: >= 5.00BRegion: USPrice: $10.00 - $150.00One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 3,000,000

Ticker

Name

Market Cap$

Lincoln National Corp

6.85B

CVS Health Corp

96.93B

Red Rock Resorts Inc

6.46B

Pinterest Inc

11.69B

Manulife Financial Corp

59.36B

Qiagen NV

10.06B

accion que comprar hoy para corto plazo

Intellectia · 399 candidates

Market Cap: >= 5.00BRsi Category: moderateList Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20One Week Predict Return: >= 0.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Sumitomo Mitsui Financial Group Inc

134.12B

APi Group Corp

18.03B

Banco Santander SA

182.13B

Cummins Inc

78.93B

Nuscale Power Corp

5.98B

GDS Holdings Ltd

8.53B

which stock to pick tomorrow

Intellectia · 158 candidates

Relative Vol: >= 1.15Weekly Average Turnover: >= 1,000,000Moving Average Relationship: PriceAboveMA5Week Price Change Pct: >= $0.00

Ticker

Name

Market Cap$

Eli Lilly and Co

1.02T

Advanced Micro Devices Inc

406.68B

Caterpillar Inc

302.02B

Amgen Inc

185.02B

Stryker Corp

138.80B

Eaton Corporation PLC

131.26B

best stocks in healthcare and energy

Intellectia · 20 candidates

Market Cap: >= 10.00BDividend Yield Ttm: >= 1Rsi 14: 55 - 65Week Price Change Pct: >= $0.00

Ticker

Name

Market Cap$

Coterra Energy Inc

20.37B

Amgen Inc

185.02B

Williams Companies Inc

77.16B

Gilead Sciences Inc

160.18B

Targa Resources Corp

40.80B

UnitedHealth Group Inc

315.01B

which are stocks are good to buy tomorrow?

Intellectia · 98 candidates

Relative Vol: >= 1.40Weekly Average Turnover: >= 2,000,000Rsi 14: 40 - 60Week Price Change Pct: >= $0.00Month Price Change Pct: >= $0.00

Ticker

Name

Market Cap$

Eli Lilly and Co

1.02T

UnitedHealth Group Inc

315.01B

Morgan Stanley

290.20B

GE Vernova Inc

181.21B

Medtronic PLC

128.57B

British American Tobacco plc

125.29B

which stock to buy for this week earnings

Intellectia · 213 candidates

Market Cap: >= 1000.00MBeta: LowRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True

Ticker

Name

Market Cap$

McDonald's Corp

217.70B

Shell PLC

209.17B

Amgen Inc

185.02B

S&P Global Inc

160.84B

Pfizer Inc

147.20B

Stryker Corp

138.80B

Add filter: beta < 1.5 and short float < 10%

Intellectia · 18 candidates

Market Cap: >= 10.00BDividend Yield Ttm: >= 3Short Ratio: LessThan10PctBeta: LowRisk, ModerateRisk

Ticker

Name

Market Cap$

Coca-Cola Co

309.76B

Mitsubishi UFJ Financial Group Inc

206.98B

CVS Health Corp

103.45B

Manulife Financial Corp

62.58B

America Movil SAB de CV

62.47B

Suncor Energy Inc (Canada)

60.68B

what stocks are primed to breakout soon?

Intellectia · 610 candidates

Weekly Average Turnover: >= 1,000,000Rsi 14: 40 - 70Candlestick Pattern: WhiteCandlestickSupport Resistance Relationship: PriceBreakResistance

Ticker

Name

Market Cap$

Johnson & Johnson

525.25B

Home Depot Inc

382.91B

Coca-Cola Co

309.76B

Thermo Fisher Scientific Inc

239.06B

Amphenol Corp

189.24B

Amgen Inc

185.02B

What stocks in US markets have higjest PE

Intellectia · 17 candidates

Market Cap: >= 50.00BRegion: USWeekly Average Turnover: >= 1,000,000Pe Ttm: >= 100

Ticker

Name

Market Cap$

Intel Corp

258.77B

Palantir Technologies Inc

394.05B

BP PLC

92.25B

Tesla Inc

1.43T

Takeda Pharmaceutical Co Ltd

51.17B

CVS Health Corp

103.45B

strong buy stocks today

Intellectia · 61 candidates

Analyst Consensus: Strong BuyWeekly Average Turnover: >= 1,000,000Rsi 14: 30 - 70Week Price Change Pct: >= $0.00Is Index Component: GSPC

Ticker

Name

Market Cap$

NVIDIA Corp

4.45T

Eli Lilly and Co

1.02T

UnitedHealth Group Inc

315.01B

Coca-Cola Co

309.76B

Thermo Fisher Scientific Inc

239.06B

Citigroup Inc

198.97B

Whales Holding CVS

Maple Rock Capital Partners Inc.

SAMA Foreign Holdings

Mubadala Investment Company PJSC

Polaris Capital Management, LLC

Epoch Investment Partners, Inc.

Macquarie Group Limited

Trading Trends

People Also Watch

Frequently Asked Questions

What is CVS Health Corp (CVS) stock price today?

The current price of CVS is 75.72 USD — it has decreased -0.79

What is CVS Health Corp (CVS)'s business?

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

What is the price predicton of CVS Stock?

Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is96.71 USD with a low forecast of 91.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CVS Health Corp (CVS)'s revenue for the last quarter?

CVS Health Corp revenue for the last quarter amounts to 105.69B USD, increased 8.17

What is CVS Health Corp (CVS)'s earnings per share (EPS) for the last quarter?

CVS Health Corp. EPS for the last quarter amounts to 2.29 USD, increased 76.15

How many employees does CVS Health Corp (CVS). have?

CVS Health Corp (CVS) has 300000 emplpoyees as of March 12 2026.

What is CVS Health Corp (CVS) market cap?

Today CVS has the market capitalization of 96.33B USD.